CollPlant Biotechnologies Ltd (CLGN) Total liabilities 2019–2025
CollPlant Biotechnologies Ltd (CLGN) total liabilities at each fiscal year-end, per SEC filings.
$4.7MFY2025 · since FY2019: $6.7M → $4.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.7M | -10.3% |
| FY2024 | $5.2M | -9.4% |
| FY2023 | $5.8M | +5.4% |
| FY2022 | $5.5M | -10.1% |
| FY2021 | $6.1M | -4.1% |
| FY2020 | $6.4M | -4.5% |
| FY2019 | $6.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CLGN financial trends
CLGN RevenueCLGN Net incomeCLGN Net marginCLGN Gross profitCLGN Gross marginCLGN Operating incomeCLGN Operating marginCLGN Operating cash flowCLGN Free cash flowCLGN Capital expendituresCLGN Return on equityCLGN Stock buybacksCLGN Dividends paidCLGN Total assetsCLGN Shareholders’ equityCLGN overview →